Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
lactulose (cephulac) (1 trial)
rifaximin (xifaxan) (1 trial)
Brain Diseases (Phase 4)
Hepatic Encephalopathy (Phase 4)
Hypertension, Portal (Phase 4)
Liver Cirrhosis (Phase 4)
Trials (1 total)
Trial APIs (2 total)